PTP
QNTM

Platform Technology Partners’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Platform Technology Partners’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Hold
41,116
– – 0.02% 380
2026
Q1 		$199K Buy
+41,116
New +$185K 0.04% 330

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Platform Technology Partners's QNTM Position: Q2 2026 in Review

Platform Technology Partners held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q2 2026 at 41,116 shares worth $149K. The position accounts for 0.02% of the portfolio, ranked #380.

Platform Technology Partners first reported a position in QNTM in Q1 2026 and has held it in 2 quarters since. The position peaked at $199K in Q1 2026. 26 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

  • Platform Technology Partners held 41,116 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $149K as of Q2 2026.
  • Platform Technology Partners left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q2 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up 0.02% of Platform Technology Partners's portfolio in Q2 2026, its #380 holding.
  • Platform Technology Partners first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2026 and has held it in 2 quarters since.
  • Platform Technology Partners's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $199K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.